Cargando…
Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review
Neonatal hyperbilirubinemia is a frequently observed clinical situation that, sometimes, may result in complications ranging from mild neurodevelopment impairment to serious outcome of kernicterus. The rationale logic of heme oxygenase enzyme inhibition to lower bilirubin levels is intriguing. In co...
Autores principales: | Poudel, Prakar, Adhikari, Sudhir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314175/ https://www.ncbi.nlm.nih.gov/pubmed/35898803 http://dx.doi.org/10.1155/2022/2549161 |
Ejemplares similares
-
Synthesis and Spectral Evaluation of Some Unsymmetrical Mesoporphyrinic Complexes
por: Boscencu, Rica, et al.
Publicado: (2012) -
Neonatal hyperbilirubinemia
por: Ben, Matteo Dal, et al.
Publicado: (2014) -
Interaction of human telomeric DNA with N-methyl mesoporphyrin IX
por: Nicoludis, John M., et al.
Publicado: (2012) -
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
por: Rasiah, Saisujani, et al.
Publicado: (2023) -
Neurobehavior of term neonates with neonatal hyperbilirubinemia
por: Babu, Thirunavukkarasu Arun, et al.
Publicado: (2013)